Connected Drug Delivery Devices Market Report by Product (Connected Sensors, Integrated Connected Devices), End User (Hospitals and Healthcare Providers, Homecare), Technology (Bluetooth, NFC, and Others), and Region 2024-2032
The global connected drug delivery devices market size reached US$ 864.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032. The demand for remote monitoring and telemedicine, rising aging population, and increasing occurrence of chronic obstructive pulmonary disease (COPD) are some of the key factors strengthening the growth of the market.
Connected Drug Delivery Devices Market Analysis:
Growing aging population
As people are aging, they are encountering greater risk of continual ailments like diabetes, high blood pressure, and cardiovascular diseases. Connected drug delivery devices play an important role in handling those situations effectively by ensuring precise medicinal drug dosing and monitoring. Moreover, these devices can simplify those regimens through reminders, tracking dosages, and transmitting records mechanically to healthcare companies. Connected drug delivery devices allow remote tracking of medicine adherence and fitness parameters. This allows healthcare companies to intervene the issues early, thus supporting aging in place. An article published on the website of the World Health Organization (WHO) shows that individuals aged over 60 are expected to double by 2050, reaching nearly 2.1 billion worldwide.
Rising prevalence of chronic obstructive pulmonary disease (COPD)
As per the content updated in 2023 on the website of the World Health Organization (WHO), nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD patients require precise and managed delivery of medicinal drugs which include bronchodilators and corticosteroids. Connected drug delivery devices ensure correct dosing and timely administration, which is vital for coping with COPD signs effectively. In addition, connected devices can monitor inhalation strategies and provide feedback to patients in actual-time. This allows COPD sufferers optimize their inhalation approach, making sure that they obtain the maximum benefits from their medicines. In line with this, COPD is a revolutionary disease that requires continuous monitoring of symptoms and lung function. Connected devices permit for remote monitoring of COPD patients' fitness fame, consisting of lung feature tests and symptom monitoring, facilitating early detection of exacerbations and timely adjustments to treatment plans.
Thriving telemedicine sector
The IMARC Group’s report shows that the global telemedicine market reached US$ 74.7 Billion in 2023. Telemedicine platforms facilitate remote consultations between healthcare providers and patients. Connected drug delivery devices supplement telemedicine by allowing actual-time tracking of patients' medication adherence, treatment response, and fitness status. This ongoing monitoring is beneficial for continual sickness management in conditions like diabetes, high blood pressure, and respiratory illnesses. Additionally, connected drug delivery devices can be incorporated with telehealth structures, permitting healthcare companies to remotely alter medicine dosages, provide customized care plans, and monitor person development. This integration improves the performance and effectiveness of telemedicine consultations by using actionable statistics and insights directly from the patient's home.
Connected Drug Delivery Devices Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, end user, and technology.
Breakup by Product:
The report has provided a detailed breakup and analysis of the market based on the product. This includes connected sensors (connected inhaler sensors, connectable injection sensors) and integrated connected devices (connected inhalation devices, connected injection devices). According to the report, connected sensors represent the largest segment.
Connected sensors enable real-time tracking and facts collection, permitting healthcare providers to remotely track patient adherence to medicinal drug regimens and physiological responses. This level of connectivity improves the quality of treatment by guaranteeing timely interventions and subsequent modification. In addition, connected sensors enhance efficient and effective patient engagement and involvement in their treatment processes. As the demand for personalized medicine is growing, connected drug delivery devices equipped with sensors provide valuable insights into patient health metrics, improving treatment efficiency and reducing healthcare costs associated with complications from non-adherence or suboptimal therapy.
Breakup by End User:
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and healthcare providers and homecare. According to the report, hospitals and healthcare providers account for the largest market share.
Hospitals and healthcare providers prioritize patient care and safety, which are significantly enhanced by connected devices that enable precise medication administration and monitoring. Connected drug delivery devices offer real-time data on patient adherence, dosage accuracy, and treatment effectiveness, thereby improving clinical outcomes and reducing errors. Furthermore, the use of digital health solutions by the healthcare providers is rising because of better efficiency of work and utilization of resources. Smart devices work with EHRs and other hospital software and platforms, allowing them to share data seamlessly and improve the productivity of the hospital.
Breakup by Technology:
The report has provided a detailed breakup and analysis of the market based on the technology. This includes Bluetooth, NFC, and other technologies. According to the report, Bluetooth represents the largest segment.
Bluetooth-enabled gadgets facilitate easier integration with smartphones and tablets, empowering patients to control their health effectively via user-pleasant interfaces and mobile apps. The comfort and reliability of Bluetooth connectivity is assisting the increase of connected drug delivery devices, as healthcare vendors are looking to leverage virtual fitness solutions for higher patient engagement and treatment adherence. Besides this, by means of integrating Bluetooth connectivity into drug delivery devices, key players can provide greater functionalities like remote monitoring, facts series, and real-time verbal exchange with healthcare carriers and patients.
Breakup by Region:
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for connected drug delivery devices.
As per the content updated in 2023 on the website of Centers for Medicare & Medicaid Services, U.S. health care spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. The increasing healthcare expenditure reflects a greater emphasis on improving patient outcomes and reducing overall healthcare costs through innovative technologies. North America has a strong presence of pharmaceutical companies and medical device manufacturers that are investing heavily in research and development (R&D) activities of connected drug delivery devices. These companies are leveraging advancements in Internet of Things (IoT) and digital connectivity to develop innovative devices that enhance medication adherence, patient monitoring, and overall treatment outcomes. Furthermore, favorable reimbursement policies and supportive regulatory frameworks in the region contribute to the rapid growth of this market segment.
Competitive Landscape:
Connected Drug Delivery Devices Market Analysis:
- Major Market Drivers: There is a rise in demand for improved patient treatment outcomes and cost of medical management.
- Key Market Trends: The growing preferences for home-based care and increasing number of chronic diseases are offering a favorable market outlook.
- Geographical Trends: North America holds the largest segment because of strong healthcare infrastructure and ongoing innovations in technology.
- Competitive Landscape: Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc., among many others.
- Challenges and Opportunities: While the market faces challenges like concerns about patient treatments data security, which impacts the market, it also encounters opportunities in maintaining electronic health records (EHR).
Growing aging population
As people are aging, they are encountering greater risk of continual ailments like diabetes, high blood pressure, and cardiovascular diseases. Connected drug delivery devices play an important role in handling those situations effectively by ensuring precise medicinal drug dosing and monitoring. Moreover, these devices can simplify those regimens through reminders, tracking dosages, and transmitting records mechanically to healthcare companies. Connected drug delivery devices allow remote tracking of medicine adherence and fitness parameters. This allows healthcare companies to intervene the issues early, thus supporting aging in place. An article published on the website of the World Health Organization (WHO) shows that individuals aged over 60 are expected to double by 2050, reaching nearly 2.1 billion worldwide.
Rising prevalence of chronic obstructive pulmonary disease (COPD)
As per the content updated in 2023 on the website of the World Health Organization (WHO), nearly 90% of COPD deaths in those under 70 years of age occur in low- and middle-income countries. COPD patients require precise and managed delivery of medicinal drugs which include bronchodilators and corticosteroids. Connected drug delivery devices ensure correct dosing and timely administration, which is vital for coping with COPD signs effectively. In addition, connected devices can monitor inhalation strategies and provide feedback to patients in actual-time. This allows COPD sufferers optimize their inhalation approach, making sure that they obtain the maximum benefits from their medicines. In line with this, COPD is a revolutionary disease that requires continuous monitoring of symptoms and lung function. Connected devices permit for remote monitoring of COPD patients' fitness fame, consisting of lung feature tests and symptom monitoring, facilitating early detection of exacerbations and timely adjustments to treatment plans.
Thriving telemedicine sector
The IMARC Group’s report shows that the global telemedicine market reached US$ 74.7 Billion in 2023. Telemedicine platforms facilitate remote consultations between healthcare providers and patients. Connected drug delivery devices supplement telemedicine by allowing actual-time tracking of patients' medication adherence, treatment response, and fitness status. This ongoing monitoring is beneficial for continual sickness management in conditions like diabetes, high blood pressure, and respiratory illnesses. Additionally, connected drug delivery devices can be incorporated with telehealth structures, permitting healthcare companies to remotely alter medicine dosages, provide customized care plans, and monitor person development. This integration improves the performance and effectiveness of telemedicine consultations by using actionable statistics and insights directly from the patient's home.
Connected Drug Delivery Devices Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on product, end user, and technology.
Breakup by Product:
- Connected Sensors
- Connected Inhaler Sensors
- Connectable Injection Sensors
- Integrated Connected Devices
- Connected Inhalation Devices
- Connected Injection Devices
The report has provided a detailed breakup and analysis of the market based on the product. This includes connected sensors (connected inhaler sensors, connectable injection sensors) and integrated connected devices (connected inhalation devices, connected injection devices). According to the report, connected sensors represent the largest segment.
Connected sensors enable real-time tracking and facts collection, permitting healthcare providers to remotely track patient adherence to medicinal drug regimens and physiological responses. This level of connectivity improves the quality of treatment by guaranteeing timely interventions and subsequent modification. In addition, connected sensors enhance efficient and effective patient engagement and involvement in their treatment processes. As the demand for personalized medicine is growing, connected drug delivery devices equipped with sensors provide valuable insights into patient health metrics, improving treatment efficiency and reducing healthcare costs associated with complications from non-adherence or suboptimal therapy.
Breakup by End User:
- Hospitals and Healthcare Providers
- Homecare
A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals and healthcare providers and homecare. According to the report, hospitals and healthcare providers account for the largest market share.
Hospitals and healthcare providers prioritize patient care and safety, which are significantly enhanced by connected devices that enable precise medication administration and monitoring. Connected drug delivery devices offer real-time data on patient adherence, dosage accuracy, and treatment effectiveness, thereby improving clinical outcomes and reducing errors. Furthermore, the use of digital health solutions by the healthcare providers is rising because of better efficiency of work and utilization of resources. Smart devices work with EHRs and other hospital software and platforms, allowing them to share data seamlessly and improve the productivity of the hospital.
Breakup by Technology:
- Bluetooth
- NFC
- Other Technologies
The report has provided a detailed breakup and analysis of the market based on the technology. This includes Bluetooth, NFC, and other technologies. According to the report, Bluetooth represents the largest segment.
Bluetooth-enabled gadgets facilitate easier integration with smartphones and tablets, empowering patients to control their health effectively via user-pleasant interfaces and mobile apps. The comfort and reliability of Bluetooth connectivity is assisting the increase of connected drug delivery devices, as healthcare vendors are looking to leverage virtual fitness solutions for higher patient engagement and treatment adherence. Besides this, by means of integrating Bluetooth connectivity into drug delivery devices, key players can provide greater functionalities like remote monitoring, facts series, and real-time verbal exchange with healthcare carriers and patients.
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for connected drug delivery devices.
As per the content updated in 2023 on the website of Centers for Medicare & Medicaid Services, U.S. health care spending grew 4.1 percent in 2022, reaching $4.5 trillion or $13,493 per person. The increasing healthcare expenditure reflects a greater emphasis on improving patient outcomes and reducing overall healthcare costs through innovative technologies. North America has a strong presence of pharmaceutical companies and medical device manufacturers that are investing heavily in research and development (R&D) activities of connected drug delivery devices. These companies are leveraging advancements in Internet of Things (IoT) and digital connectivity to develop innovative devices that enhance medication adherence, patient monitoring, and overall treatment outcomes. Furthermore, favorable reimbursement policies and supportive regulatory frameworks in the region contribute to the rapid growth of this market segment.
Competitive Landscape:
- The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the connected drug delivery devices industry include Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.
- Key players continuously improving sensor technology, connectivity solutions, and mobile health applications to enhance the functionality, reliability, and user experience of connected drug delivery devices. They are also integrating connected drug delivery devices with digital health platforms and electronic medical records (EMRs) to facilitate seamless data exchange, real-time monitoring, and personalized healthcare interventions. Moreover, many companies are developing user-friendly interfaces, mobile apps, and educational resources to enhance patient engagement, adherence to treatment regimens, and self-management of chronic conditions. They are also developing connected drug delivery devices that support personalized medicine approaches, such as dose adjustments based on real-time data and patient-specific health information. For instance, in 2023, Merck, a leading science and technology company collaborated with BenevolentAI and Exscientia to strengthen AI-driven drug discovery.
- May 24, 2024: Adherium Limited, a leader in respiratory eHealth, remote monitoring and data management solutions, announced that AstraZeneca has selected its Hailie® Smartinhaler® platform for a clinical trial. This contract is valued at $1.1M over the course of three years.
- June 6, 2023: Novo Nordisk acquired medical device manufacturer Biocorp for Ђ154 million.
- How has the global connected drug delivery devices market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global market?
- What is the impact of each driver, restraint, and opportunity on the global market?
- What are the key regional markets?
- Which countries represent the most attractive market?
- What is the breakup of the market based on the product?
- Which is the most attractive product in the connected drug delivery devices market?
- What is the breakup of the market based on the end user?
- Which is the most attractive end user in the connected drug delivery devices market?
- What is the breakup of the market based on the technology?
- Which is the most attractive technology in the connected drug delivery devices market?
- What is the breakup of the market based on the region?
- Which is the most attractive region in the connected drug delivery devices market?
- What is the competitive structure of the market?
- Who are the key players/companies in the global connected drug delivery devices market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Connected Sensors
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Connected Inhaler Sensors
6.1.2.2 Connectable Injection Sensors
6.1.3 Market Forecast
6.2 Integrated Connected Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Connected Inhalation Devices
6.2.2.2 Connected Injection Devices
6.2.3 Market Forecast
7 MARKET BREAKUP BY END USER
7.1 Hospitals and Healthcare Providers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Homecare
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Bluetooth
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 NFC
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Other Technologies
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adherium Limited
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 BioCorp Production
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Cohero Health Inc. (AptarGroup Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Elcam Medical ACS. Ltd
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Findair Sp. z o. o.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Phillips Medisize (Molex LLC)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Propeller Health (Resmed Inc.)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 West Pharmaceutical Services Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Connected Sensors
6.1.1 Market Trends
6.1.2 Key Segments
6.1.2.1 Connected Inhaler Sensors
6.1.2.2 Connectable Injection Sensors
6.1.3 Market Forecast
6.2 Integrated Connected Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Connected Inhalation Devices
6.2.2.2 Connected Injection Devices
6.2.3 Market Forecast
7 MARKET BREAKUP BY END USER
7.1 Hospitals and Healthcare Providers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Homecare
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY TECHNOLOGY
8.1 Bluetooth
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 NFC
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Other Technologies
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Adherium Limited
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 BioCorp Production
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3 Cohero Health Inc. (AptarGroup Inc.)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Elcam Medical ACS. Ltd
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Findair Sp. z o. o.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck KGaA
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Phillips Medisize (Molex LLC)
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Propeller Health (Resmed Inc.)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 West Pharmaceutical Services Inc.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
Table 7: Global: Connected Drug Delivery Devices Market: Key Players
Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
Table 7: Global: Connected Drug Delivery Devices Market: Key Players
LIST OF FIGURES
Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2023
Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2023
Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2023
Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2023
Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis
Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2023
Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2023
Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2023
Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2023
Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis
